Quantbot Technologies’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quantbot Technologies’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-272	Closed	-$5K	–	2077
2021 Q3	$5K	Buy	+272	New	+$7.51K	﹤0.01%	1413
2021 Q1	–	Sell	-1,256	Closed	-$27K	–	1887
2020 Q4	$27K	Buy	+1,256	New	+$27.7K	﹤0.01%	969
2019 Q3	–	Sell	-3,800	Closed	-$59K	–	1669
2019 Q2	$59K	Buy	+3,800	New	+$51.7K	0.01%	869
2018 Q4	–	Sell	-6,193	Closed	-$94K	–	1556
2018 Q3	$94K	Sell	6,193 -6,614	-52%	-$96.3K	0.01%	895
2018 Q2	$156K	Buy	+12,807	New	+$161K	0.01%	783

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Quantbot Technologies's DRNA Position: Q4 2021 in Review

Quantbot Technologies sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 272 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in DRNA in Q2 2018 and held it in 5 quarters. The position peaked at $156K in Q2 2018. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Quantbot Technologies reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Quantbot Technologies sold 272 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $5K.
Quantbot Technologies first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 5 quarters.
Quantbot Technologies's Dicerna Pharmaceuticals, Inc. position peaked at $156K in Q2 2018.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.